title: Mechanism of cardiovascular actions of the chromogranin A fragment catestatin in vivo.
abstract: Catestatin (bovine chromogranin A(344-364); RSMRLSFRARGYGFRGPGLQL), reduces catecholamine secretion from chromaffin cells in vitro. We investigated the effects of this peptide on catecholamine release and blood pressure in vivo. Intravenous catestatin reduced pressor responses to activation of sympathetic outflow by electrical stimulation in rats, and the catestatin effect persisted even after adrenergic (alpha plus beta) blockade. Catestatin did not alter plasma norepinephrine levels, but increased plasma epinephrine 11-fold. Catestatin also blunted pressor responses to exogenous neuropeptide Y agonists. A control peptide (chromogranin A(141-160)) did not alter pressor or catecholamine responses to electrical stimulation. Pretreatment with a histamine H1 receptor antagonist blocked both the vasodepressor response to catestatin and the elevation in plasma epinephrine. Catestatin elevated endogenous circulating histamine 21-fold, and exogenous histamine mimicked both the epinephrine elevation and the vasodepressor actions of catestatin. We conclude that catestatin is a potent vasodilator in vivo whose actions appear to be mediated, at least in part, by histamine release and action at H1 receptors.
authors.affiliation: Department of Medicine and Center for Molecular Genetics, University of California, and VA San Diego Healthcare System, USA.
authors.forename: B P
authors.initials: BP
authors.lastname: Kennedy
authors.forename: S K
authors.initials: SK
authors.lastname: Mahata
authors.forename: D T
authors.initials: DT
authors.lastname: O'Connor
authors.forename: M G
authors.initials: MG
authors.lastname: Ziegler
mesh_terms: D018674:Adrenergic Antagonists / Q000494:pharmacology; D000595:Amino Acid Sequence; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D053379:Chromogranin A; D002864:Chromogranins / Q000494:pharmacology*; D004558:Electric Stimulation; D004837:Epinephrine / Q000097:blood; D006632:Histamine / Q000097:blood / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D006919:Hydroxyzine / Q000494:pharmacology; D008297:Male; D008969:Molecular Sequence Data; D009478:Neuropeptide Y / Q000819:agonists / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D009638:Norepinephrine / Q000097:blood; D010446:Peptide Fragments / Q000494:pharmacology*; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D017433:Protein Structure, Secondary; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D018674:Adrenergic Antagonists; D053379:Chromogranin A; D002864:Chromogranins; D006634:Histamine H1 Antagonists; D009478:Neuropeptide Y; D010446:Peptide Fragments; C109084:chromogranin A (344-364); C506153:chromogranin A, rat; D010643:Phenoxybenzamine; D006919:Hydroxyzine; D006632:Histamine; D011433:Propranolol; D009638:Norepinephrine; D004837:Epinephrine